Efficacy and Safety of Atorvastatin 40 mg versus Rosuvastatin 20 mg in Patients with Type 2 Diabetes Mellitus and Previous Acute Coronary Syndrome: A Randomized Clinical Trial

BACKGROUND: The purpose of this study was to compare the efficacy and safety of high-dose atorvastatin (40 mg) versus high-dose rosuvastatin (20 mg) in Egyptian patients with type 2 diabetes and previous acute coronary syndrome history. MATERIALS AND METHODS: This open-labeled prospective, randomize...

Descrición completa

Detalles Bibliográficos

Principais autores:	Abdel-Hameed Ibrahim Mohamed Ebid, Yasmine Magdy Fahim Genina, Abdul-Majeed Abdulfattah Al-Jendy, Amira Mohamed El-Sawy
Formato:	Artigo
Idioma:	Inglês
Publicado:	Via Medica 2022-06-01
Series:	Clinical Diabetology
Assuntos:	Acute coronary syndrome diabetes mellitus high-intensity statin therapy atorvastatin rosuvastatin
Acceso en liña:	https://journals.viamedica.pl/clinical_diabetology/article/view/88638
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!